Orrick

Orrick is fundamentally a global law firm that also operates an investment arm. The firm's website describes no separate asset management brand; the investment function appears to be a direct principal-investing activity housed within the law firm partnership. The precise legal structure of the investing entity is not publicly disclosed, but Altss research identifies it as deploying capital into venture-stage companies.

Orrick's primary deal flow derives from its position as a major global law firm. The firm advises technology, energy, and life sciences companies on transactional and regulatory matters, creating a unique sourcing pipeline for its investment arm. This inside-view approach allows Orrick to evaluate potential portfolio companies through a legal and commercial lens before competitors see the opportunity.

Per Altss research, Orrick's investment arm targets early-stage companies (including Seed and Start-up rounds) and growth-stage investments. The firm also participates in venture debt transactions, providing a broader capital solutions toolkit than a pure equity investor.

The firm concentrates on four core sectors that mirror its law firm's client base: technology & innovation, energy & infrastructure, life sciences & healthtech, and finance. Geographically, the investment arm is anchored in the United States, with a focus on West Coast innovation hubs, though the law firm's international offices suggest a scope that extends to cross-border deals.

No. Orrick does not publicly disclose assets under management, fund sizes, or a full list of portfolio companies. The investment platform operates with limited transparency relative to traditional venture capital firms, and no specific named holdings have been confirmed through the firm's own communications.